Katrin F. Chua

Dr. Katrin F. Chua

Stanford Medicine
+1
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Cell
Verified
Journal Article
Closed access
TKTiara L.A. Kawahara
Tiara L.A. Kawahara
EMEriko Michishita
Eriko Michishita
AAAdam Adler
Adam Adler
MDMara Damian
Mara Damian
EBElisabeth Berber
Elisabeth Berber
KCKatrin F. Chua
Katrin F. Chua

12 March 2008 in Nature
Verified
Journal Article
Closed access
PDF file
EMEriko Michishita
Eriko Michishita
RMRonald A. McCord
Ronald A. McCord
EBElisabeth Berber
Elisabeth Berber
MKMitomu Kioi
Mitomu Kioi
HPHesed Padilla-Nash
Hesed Padilla-Nash
KCKatrin F. Chua
Katrin F. Chua

6 May 2012 in Nature
Verified
Journal Article
Open access
PDF file
MBMatthew F. Barber
Matthew F. Barber
EMEriko Michishita-Kioi
Eriko Michishita-Kioi
YXYuanxin Xi
Yuanxin Xi
LTLuisa Tasselli
Luisa Tasselli
MKMitomu Kioi
Mitomu Kioi
KCKatrin F. Chua
Katrin F. Chua
SIRT7 is an H3K18Ac-selective deacetylase that has a pivotal role in chromatin regulation, maintenance of cellular transformation programs and tumour formation in vivo. The mammalian sirtuin protein SIRT7 has been linked to the transcription of ribosomal RNA but, unlike other known human sirtuins, its substrates and physiological function are not clear. This paper reports an enzyme activity for SIRT7 and provides several strands of evidence linking SIRT7 activity to the maintenance of fundamental cancer-cell phenotypes and tumour progression. SIRT7 acts as a histone deacetylase specific for H3 lysine 18, and promotes transcriptional repression. SIRT7 target genes have links to tumour suppression, and the oncogenic transcription factor ELK4 can recruit SIRT7 to target promoters. SIRT7 is required for the maintenance of cellular transformation and tumour growth in mice. Sirtuin proteins regulate diverse cellular pathways that influence genomic stability, metabolism and ageing1,2. SIRT7 is a mammalian sirtuin whose biochemical activity, molecular targets and physiological functions have been unclear. Here we show that SIRT7 is an NAD+-dependent H3K18Ac (acetylated lysine 18 of histone H3) deacetylase that stabilizes the transformed state of cancer cells. Genome-wide binding studies reveal that SIRT7 binds to promoters of a specific set of gene targets, where it deacetylates H3K18Ac and promotes transcriptional repression. The spectrum of SIRT7 target genes is defined in part by its interaction with the cancer-associated E26 transformed specific (ETS) transcription factor ELK4, and comprises numerous genes with links to tumour suppression. Notably, selective hypoacetylation of H3K18Ac has been linked to oncogenic transformation, and in patients is associated with aggressive tumour phenotypes and poor prognosis3,4,5,6. We find that deacetylation of H3K18Ac by SIRT7 is necessary for maintaining essential features of human cancer cells, including anchorage-independent growth and escape from contact inhibition. Moreover, SIRT7 is necessary for a global hypoacetylation of H3K18Ac associated with cellular transformation by the viral oncoprotein E1A. Finally, SIRT7 depletion markedly reduces the tumorigenicity of human cancer cell xenografts in mice. Together, our work establishes SIRT7 as a highly selective H3K18Ac deacetylase and demonstrates a pivotal role for SIRT7 in chromatin regulation, cellular transformation programs and tumour formation in vivo.

15 August 2009 in Cell Cycle
Verified
Journal Article
Closed access
EMEriko Michishita
Eriko Michishita
RMRonald A. McCord
Ronald A. McCord
LBLisa D. Boxer
Lisa D. Boxer
MBMatthew F. Barber
Matthew F. Barber
THTao Hong
Tao Hong
KCKatrin F. Chua
Katrin F. Chua
(2009). Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle: Vol. 8, No. 16, pp. 2664-2666.

1 November 2013 in Cell Reports
Verified
Journal Article
Open access
JSJiyung Shin
Jiyung Shin
MHMing He
Ming He
YLYufei Liu
Yufei Liu
SPSilvana Paredes
Silvana Paredes
LVLidia Villanova
Lidia Villanova
DCDanica Chen
Danica Chen
Nonalcoholic fatty liver disease is the most common chronic liver disorder in developed countries. Its pathogenesis is poorly understood, and therapeutic options are limited. Here, we show that SIRT7, an NAD(+)-dependent H3K18Ac deacetylase, functions at chromatin to suppress ER stress and prevent the development of fatty liver disease. SIRT7 is induced upon ER stress and is stabilized at the promoters of ribosomal proteins through its interaction with the transcription factor Myc to silence gene expression and to relieve ER stress. SIRT7-deficient mice develop chronic hepatosteatosis resembling human fatty liver disease. Myc inactivation or pharmacological suppression of ER stress alleviates fatty liver caused by SIRT7 deficiency. Importantly, SIRT7 suppresses ER stress and reverts the fatty liver disease in diet-induced obese mice. Our study identifies SIRT7 as a cofactor of Myc for transcriptional repression and delineates a druggable regulatory branch of the ER stress response that prevents and reverts fatty liver disease.

15 January 2009 in Aging
Verified
Journal Article
Open access
RMRonald A. McCord
Ronald A. McCord
EMEriko Michishita
Eriko Michishita
THTao Hong
Tao Hong
EBElisabeth Berber
Elisabeth Berber
LBLisa D. Boxer
Lisa D. Boxer
KCKatrin F. Chua
Katrin F. Chua
The Sir2 chromatin regulatory factor links maintenance of genomic stability to life span extension in yeast. The mammalian Sir2 family member SIRT6 has been proposed to have analogous functions, because SIRT6-deficiency leads to shortened life span and an aging-like degenerative phenotype in mice, and SIRT6 knockout cells exhibit genomic instability and DNA damage hypersensitivity. However, the molecular mechanisms underlying these defects are not fully understood. Here, we show that SIRT6 forms a macromolecular complex with the DNA double-strand break (DSB) repair factor DNA-PK (DNA-dependent protein kinase) and promotes DNA DSB repair. In response to DSBs, SIRT6 associates dynamically with chromatin and is necessary for an acute decrease in global cellular acetylation levels on histone H3 Lysine 9. Moreover, SIRT6 is required for mobilization of the DNA-PK catalytic subunit (DNA-PKcs) to chromatin in response to DNA damage and stabilizes DNA-PKcs at chromatin adjacent to an induced site-specific DSB. Abrogation of these SIRT6 activities leads to impaired resolution of DSBs. Together, these findings elucidate a mechanism whereby regulation of dynamic interaction of a DNA repair factor with chromatin impacts on the efficiency of repair, and establish a link between chromatin regulation, DNA repair, and a mammalian Sir2 factor.